Mycophenolate mofetil and Augmentin '125' drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Augmentin '125' (amoxicillin; clavulanate potassium). Common drug interactions include jaw fracture among females and hydronephrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Augmentin '125'. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.



On Jul, 11, 2026

33 people who take Mycophenolate mofetil and Augmentin '125' together, and have interactions are studied.

Mycophenolate mofetil and Augmentin '125' drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Augmentin '125', by gender? *:

female:

  1. Jaw fracture
  2. Magnesium deficiency (lack of magnesium)
  3. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
  4. Nausea (feeling of having an urge to vomit)
  5. Neoplasm malignant (cancer tumour)
  6. Oedema (fluid collection in tissue)
  7. Osteitis (a general term for inflammation of bone)
  8. Osteonecrosis of jaw (death of bone of jaw)
  9. Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
  10. Renal failure acute (rapid kidney dysfunction)

male:

  1. Hydronephrosis (water inside the kidney)
  2. Complications of transplanted kidney
  3. Renal impairment (severely reduced kidney function)
  4. Lymphatic disorder (disease of lymphatic system)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Obstructive uropathy (a blockage that prevents urine from leaving your kidneys)
  7. Peritonitis sclerosing (rare form of peritoneal inflammation)
  8. Reperfusion injury (tissue damage caused when blood supply returns to the tissue after a period of ischemia or lack of oxygen)
  9. Scar
  10. Scar pain

What are the common drug interactions of Mycophenolate Mofetil and Augmentin '125', by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
  2. Pneumonia

20-29:

  1. Complications of transplanted kidney
  2. Hydronephrosis (water inside the kidney)
  3. Urinary tract infection

30-39:

  1. Blood creatinine increased
  2. Pyelonephritis acute (sudden inflammation of kidney caused by bacteria)
  3. Pyrexia (fever)
  4. Renal artery stenosis (narrowing of renal artery)
  5. Renal impairment (severely reduced kidney function)
  6. Varicella
  7. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)

40-49:

  1. Hypotension (abnormally low blood pressure)
  2. Loss of consciousness
  3. Microangiopathy (disease of the capillaries (very small blood vessels), in which the capillary walls become so thick and weak that they bleed, leak protein)
  4. Pyrexia (fever)
  5. Renal failure (kidney dysfunction)
  6. Skin lesion
  7. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  8. Vision blurred
  9. Acarodermatitis (skin inflammation caused by mites (acarids))
  10. Alanine aminotransferase increased

50-59:

  1. Leukopenia (less number of white blood cells in blood)
  2. Peritonitis sclerosing (rare form of peritoneal inflammation)
  3. Stomatitis necrotising (inflammation of mucous membrane of mouth with cell damage)
  4. Blood bilirubin increased
  5. Blood potassium increased
  6. Haemoglobin decreased
  7. Platelet count decreased
  8. White blood cell count decreased

60+:

  1. Leukopenia (less number of white blood cells in blood)
  2. Cytomegalovirus infection
  3. Lymphatic disorder (disease of lymphatic system)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Obstructive uropathy (a blockage that prevents urine from leaving your kidneys)
  6. Reperfusion injury (tissue damage caused when blood supply returns to the tissue after a period of ischemia or lack of oxygen)
  7. Scar
  8. Scar pain
  9. Aphthous stomatitis (mouth ulcer)
  10. Febrile neutropenia (fever with reduced white blood cells)

What are the existing conditions these people have? *

  1. Sedation: 3 people, 9.09%
  2. Anaemia (lack of blood): 3 people, 9.09%
  3. Vitamin B12 Deficiency: 2 people, 6.06%
  4. Multiple Myeloma (cancer of the plasma cells): 2 people, 6.06%
  5. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 2 people, 6.06%
  6. Immunodeficiency Disorders: 2 people, 6.06%
  7. High Blood Pressure: 2 people, 6.06%
  8. Constipation: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Augmentin '125'?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mycophenolate mofetil and Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mycophenolate mofetil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin '125' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and amoxicillin; clavulanate potassium (the active ingredients of Mycophenolate mofetil and Augmentin '125', respectively), and Mycophenolate mofetil and Augmentin '125' (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: